Your session is about to expire
← Back to Search
Cognitive enhancement therapy (CET) for Psychosis
Study Summary
This trial will look at how reducing alcohol use can improve the treatment of early phase psychosis in young people. It will measure symptoms, hospitalizations, school/work and relationships to track long-term recovery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the cut-off age for participation in this clinical trial below 35 years?
"In accordance with the trial's parameters, eligibility for this study is restricted to individuals between 16 and 35 years of age."
Are there still opportunities for patients to join this research initiative?
"According to the clinicaltrials.gov page, this trial is actively enrolling patients. The study was originally published on December 1st 2022 and underwent a revision as recently as May 3rd 2023."
How many participants have been enlisted in this medical trial?
"Accurate, according to clinicaltrials.gov this trial is still open for recruitment, having been first posted on December 1st 2022 and last edited on May 3rd 2023. The study requires 24 individuals from one single medical site."
For what demographic is the current trial recruiting?
"This medical research study seeks 24 participants ages 16-35, with a diagnosis of schizophrenia spectrum disorder and an alcohol consumption score above 8 on the World Health Organization Alcohol Use Disorders Identification Test (WHO-AUDIT). These individuals must have been in Early Intervention Services for Psychosis in Nova Scotia for less than 5 years."
Share this study with friends
Copy Link
Messenger